September is Childhood Cancer Awareness Month. 30,000 children in India and 10 times that number worldwide develop cancer every year. There is a lack of awareness and timely diagnosis to treat them. Sapien will be sharing the Indian cancer data it has throughout September, starting with colorectal cancer.

Resources: https://www.worldchildcancer.org/, https://www.indiancancersociety.org/, https://www.childrenwithcancer.org.uk/, https://curechildhoodcancer.org/,

Sapien receives DPIIT recognition

Pleased to get the certificate from #DPIIT. Heartfelt thanks to @Saravjeet Chahal who helped resolve the glitches at #StartUp India website due to CIN number mismatch.

Attention all Telangana startups that were formed in combined AP, before formation of Telangana, like #SapienBio, if you are facing persistent problems getting your application completed on #StartupIndia website, it may be due to your CIN number with AP not getting validated by MCA, and AP getting morphed to TG, which then creates other problems. Suggest contacting Saravjeet who will help. The tollfree call numbers did not. Thank you #nitiayog and @Sanjana Mohanty, @Aastha Grover for helping resolve our 8 month long quest for recognition.

 

Rejig.HydStartups kick-off G.R.O.W

 

First of the Rejig.Hyderabad marathon sessions happened yesterday evening. A total of 13 companies, broadly in area of healthcare, were given 3 minutes each to pitch virtually in front of 4 mentors: @Ambuj Chaturvedi, @Vijay Bhaskar, @Neetika Maheshwari, @Vivek Bhargava, with @Paridhi Gupta and @Ramjee Pallela diligently keeping us all on time. It was heartening to get instant mentor feedback to our pitch for growth funds in that they all said Sapien had clearly proven traction and market validation for its services and products. They were keen to see our roadmap for scale-up, product and IP potential, and interested in seeing how the structured patient data we have built up carefully for breast, lung, renal, colorectal, gliomas etc. could be made available for research at universities to build data analytics & AI capabilities.  I look forward to the 1-on-1 mentoring sessions to help refine our pitch for success.

To contact us – please write to queries@sapienbio.com

Sapien Biosciences selected for Rejig.HydStartups Corporate Market Access and Investor Program

 

Rejig.HydStartups has selected 100 start-ups for programs that help them reposition their business models post-pandemic. Sapien Biosciences is one of the lucky companies selected for the Corporate Market Access and Investors Program.

 

https://www.newindianexpress.com/cities/hyderabad/2020/aug/04/rejig-hydstartups-handpicks-100-startups-for-mega-mentorship-project-2178672.html

Our CEO, Dr. Jugnu Jain, wins Niti-Aaayog’s Women Transforming India Award on International Women’s Day, March 2020.

https://www.youtube.com/watch?v=Grg30L36B50

 

The Women Transforming India (WTI) Awards is NITI Aayog’s annual initiative to highlight the commendable and groundbreaking endeavours of India’s women leaders and changemakers. In 2018, the Awards were brought under the aegis of NITI Aayog’s Women Entrepreneurship Platform (WEP) and have had a special focus on entrepreneurship ever since. Through the WTI Awards, NITI Aayog hopes to celebrate and bring to the national platform exceptional women entrepreneurs who have broken the glass ceiling with their grit and determination.

The Fourth Edition of the WTI Awards built on last year’s theme of ‘Women and Entrepreneurship’ was announced in August 2019. NITI Aayog received over 2300 applications from across the country in November, 2019. On 8th March 2020, the Top 15 women entrepreneurs were awarded at the Women Transforming India Awards ceremony held at Sushma Swaraj Bhawan in New Delhi.

Sapien’s breast cancer database showcased @BioAsia2020, shortlisted by an expert selection committee for Startup Stage @ BioAsia 2020.

 

 

 

 

Sapien Biosciences team @ BioAsia 2020, at Stall # S14. Sapien was selected from the Startup Stage competition and awarded free exhibit space and delegate pass at BioAsia. Here we showcased several breast cancer patients’ tissue-derived in vitro models for testing new drugs and markers at Sapien. The deep database of ~10,000 Indian breast cancer patients’ data was also showcased. These data can be used for developing Artificial Intelligence-based algorithms to improve the diagnosis, treatment and survival of future breast cancer patients.